Cargando…

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19

To reduce Coronavirus Disease 2019 (COVID-19)-related mortality and morbidity, widely available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as fluvoxamine or fluoxetine, may be beneficial against COVID-19. We included 388,945 adult inpatients who tested positive for S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoertel, Nicolas, Sánchez-Rico, Marina, Kornhuber, Johannes, Gulbins, Erich, Reiersen, Angela M., Lenze, Eric J., Fritz, Bradley A., Jalali, Farid, Mills, Edward J., Cougoule, Céline, Carpinteiro, Alexander, Mühle, Christiane, Becker, Katrin Anne, Boulware, David R., Blanco, Carlos, Alvarado, Jesús M., Strub-Wourgaft, Nathalie, Lemogne, Cédric, Limosin, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572995/ https://www.ncbi.nlm.nih.gov/pubmed/36233753 http://dx.doi.org/10.3390/jcm11195882

Ejemplares similares

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19
por: Hoertel, N., et al.
Publicado: (2023)

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID‐19: An Observational Multicenter Study
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter study
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
por: Hoertel, Nicolas, et al.
Publicado: (2023)

Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2
por: Fritz, Bradley A., et al.
Publicado: (2022)

Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality: Results from 49,089 COVID-19 inpatients
por: Hoertel, Nicolas, et al.
Publicado: (2021)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, David, et al.
Publicado: (2022)

Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model
por: Péricat, D., et al.
Publicado: (2023)

Risk of Death in Individuals Hospitalized for COVID-19 With and Without Psychiatric Disorders: An Observational Multicenter Study in France
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Association between benzodiazepine receptor agonist use and mortality in patients hospitalised for COVID-19: a multicentre observational study
por: Hoertel, N., et al.
Publicado: (2022)

New Molecular Targets for Antidepressant Drugs
por: Kornhuber, Johannes, et al.
Publicado: (2021)

The acid sphingomyelinase/ceramide system in COVID-19
por: Kornhuber, Johannes, et al.
Publicado: (2021)

Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Retirement age does not modify the association of prior working conditions with self-rated health and mortality in retirees: results from a prospective study of retired French workers
por: Hoertel, Nicolas, et al.
Publicado: (2022)

Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells
por: Carpinteiro, Alexander, et al.
Publicado: (2021)

Outcomes associated with antidepressant treatment according to the number of prescriptions and treatment changes: 5-year follow-up of a nation-wide cohort study
por: Ouazana-Vedrines, Charles, et al.
Publicado: (2022)

Peripheral Acid Sphingomyelinase Activity Is Associated with Biomarkers and Phenotypes of Alcohol Use and Dependence in Patients and Healthy Controls
por: Mühle, Christiane, et al.
Publicado: (2018)

Antipsychotic use and 28-day Mortality in Patients Hospitalized with COVID-19: a multicenter observational retrospective study
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Ex vivo assay to evaluate the efficacy of drugs targeting sphingolipids in preventing SARS-CoV-2 infection of nasal epithelial cells
por: Becker, Katrin Anne, et al.
Publicado: (2021)

Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
por: Schloer, Sebastian, et al.
Publicado: (2020)

Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study
por: Airagnes, Guillaume, et al.
Publicado: (2018)

Towards quantifying the reciprocal associations between frequency of cannabis use and alcohol consumption: a cross-lagged analysis from the CONSTANCES cohort
por: Airagnes, Guillaume, et al.
Publicado: (2022)

mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
por: Rhein, Cosima, et al.
Publicado: (2021)

Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
por: Loas, Gwenolé, et al.
Publicado: (2021)

Mortality in older adults with severe mental illness: the role of metabolic syndrome and its components
por: Abou Kassm, S., et al.
Publicado: (2023)

Comorbidity patterns and mortality among hospitalized patients with psychiatric disorders and COVID-19
por: Sánchez-Rico, Marina, et al.
Publicado: (2023)

Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain
por: Zoicas, Iulia, et al.
Publicado: (2020)

Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort
por: Airagnes, Guillaume, et al.
Publicado: (2019)

Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramide
por: Gulbins, Anne, et al.
Publicado: (2018)

Depressive Symptoms and Vegetarian Diets: Results from the Constances Cohort
por: Matta, Joane, et al.
Publicado: (2018)

Secretory Acid Sphingomyelinase in the Serum of Medicated Patients Predicts the Prospective Course of Depression
por: Mühle, Christiane, et al.
Publicado: (2019)

Alcohol, tobacco and cannabis use are associated with job loss at follow-up: Findings from the CONSTANCES cohort
por: Airagnes, Guillaume, et al.
Publicado: (2019)

Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
por: Mühle, Christiane, et al.
Publicado: (2013)

Enhanced Alcohol Preference and Anxiolytic Alcohol Effects in Niemann-Pick Disease Model in Mice
por: Kalinichenko, Liubov S., et al.
Publicado: (2019)

Dietary Restrictions and Depressive Symptoms: Longitudinal Results from the Constances Cohort
por: Matta, Joane, et al.
Publicado: (2020)

Long-term care utilization within older adults with schizophrenia: Associated factors in a multicenter study
por: Pierre, L., et al.
Publicado: (2023)

Repurposing FIASMAs against Acid Sphingomyelinase for COVID-19: A Computational Molecular Docking and Dynamic Simulation Approach
por: Naz, Aliza, et al.
Publicado: (2023)

Balint groups and narrative medicine compared to a control condition in promoting students’ empathy
por: Lemogne, Cédric, et al.
Publicado: (2020)

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_teaogp4us38k7jgsnjhsfrucki